Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Up To Five S. Korean Pharmas Halt Certain Drug Sales In Asbestos Scare

This article was originally published in PharmAsia News

Executive Summary

Several South Korean pharmaceutical companies have halted sales of antibiotics and six other drugs following a discovery they might be contaminated with asbestos, a carcinogen. The names of the four or five companies believed taking the precautionary action were not released, but their drugs are said to be suspected of containing talc contaminated with asbestos. Talc often is used in the molding process and for polishing. A primary supplier was Duksan Pure Chemicals. In addition to antibiotics, possibly tainted drugs include antacids and hemostatic powder. (Click here for more)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts